China

Dr. Fauci: It ‘Boggles My Mind’ That China’s Wet Markets Aren’t Shut Down

Published

3 years ago

April 3, 2020

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told “Fox & Friends” Friday that he’s ‘mind boggled’ that the wet markets responsible for some of the world’s most infectious viruses selling exotic animals for food in China remain open.

“I have no authority to call for anything, but I can certainly tell you how I feel. I think they should shut down those things right away,” Fauci said.

He added, “It just boggles my mind how we have so many diseases that emanate out of that unusual human-animal interface that we don’t just shut it down. I don’t know what else has to happen to get us to appreciate that.”

Many medical experts, including the CDC, argue that the coronavirus may have come from a wet market in Wuhan, China, where people were eating bats and other exotic animals. China, however, recently reopened the wet markets in the country, according to reports.

Related Topics:Chinese wet markets coronavirus Dr. Fauci

Click to comment

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

2 days ago

June 7, 2023

Sara Carter Staff

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4

— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.